Dupont Capital Management Corp Aquestive Therapeutics, Inc. Transaction History

Dupont Capital Management Corp

  • $1.18 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 30, 2021
SELL
$3.29 - $5.21 $120,914 - $191,477
-36,752 Closed
0 $0
Q1 2021

Apr 29, 2021
SELL
$4.17 - $6.73 $31,429 - $50,724
-7,537 Reduced 17.02%
36,752 $191,000
Q4 2020

Jan 28, 2021
BUY
$4.65 - $7.79 $56,711 - $95,006
12,196 Added 38.0%
44,289 $237,000
Q3 2020

Oct 29, 2020
BUY
$4.12 - $9.09 $132,223 - $291,725
32,093 New
32,093 $156,000

Others Institutions Holding AQST

# of Institutions
122
Shares Held
46.8M
Call Options Held
517K
Put Options Held
207K
View Full List

About Aquestive Therapeutics, Inc.

AQST Quotes by TradingView
  • Ticker AQST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 53,350,700
  • Market Cap $178M
  • Description
  • Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...
More about AQST
Track This Portfolio

Track Dupont Capital Management Corp Portfolio

Follow Dupont Capital Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Dupont Capital Management Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email